Mainichi Daily News The scandal erupted earlier this year when it was discovered that three academic papers by a Kyoto Prefectural University of Medicine research team studying the effects of the Novartis blood pressure drug Valsartan had been withdrawn over "major ...
Economic Times The commissioning of the three blocks after securing the regulatory approvals is likely to be the key growth driver. The company has a strong pipeline of key products like Irbesartan, Latanaprost, Pregabalin and Valsartan to aid its growth through the ...
Basingstoke Observer tsar Hampshire's crime tsar Simon Hayes this week met Basingstoke's Neighbourhood Watch coordinators for the first time since his historic appointment. And the Police and Crime Commissioner for Hampshire quickly acknowledged the most vital part of the ...
Mainichi Daily News Nagoya University has launched an investigation into the suspected involvement of Novartis Pharma K.K.'s staff in clinical testing by the school's team on the pharmaceutical firm's blood pressure-lowering drug Valsartan . Nagoya University, a national ...
Forbes The Novartis Novartis statement is the latest development in a growing scandal involving clinical trials in Japan with Novartis's former blockbuster drug Diovan ( valsartan ). As previously reported here, one trial, the Kyoto Heart Study, has been ...
